PDCD1 and neoplasm: Moreover, the specific microenvironment generated by tumor releasing factors and hypoxia conditions can induce the expression of PD-L1 in MDSCs (58).They can inhibit the activation of T cells by binding with PD-1 on T cells and are immune suppressive toward T cells activated by anti-CD3 and anti-CD28 in vitro.